Regeneron Pharmaceuticals Inc
XBER:RGO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Regeneron Pharmaceuticals Inc
XBER:RGO
|
US |
Wall Street
Price Targets
RGO Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
RGO
is 149 EUR
with a low forecast of 112.82 EUR and a high forecast of 187.84 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RGO's stock price target?
Price Target
149
EUR
According to Wall Street analysts, the average 1-year price target for
RGO
is 149 EUR
with a low forecast of 112.82 EUR and a high forecast of 187.84 EUR.
What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Regeneron Pharmaceuticals Inc's revenue is
28%.
The projected
CAGR
for the next 3 years is
10%.
What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
23%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's operating income for the next 3 years is
23%.
What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
13%
The
compound annual growth rate
of Regeneron Pharmaceuticals Inc's net income for the next 3 years is
13%.
